In a sweet indication of an improving capital market for med-tech companies, Biolinq Inc. landed $58 million in bridge financing to support completion of the U.S. pivotal trial of its intradermal glucose sensor and submission to the U.S. FDA. The round brings the total raised to more than $170 million.
/PRNewswire/ The "Continuous Glucose Monitoring (CGM) Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com s offering. The.
/PRNewswire/ The "The Global Market for Wearable Electronic Skin Patches 2023-2033" report has been added to ResearchAndMarkets.com s offering. The market.
/PRNewswire/ The "The Global Market for Wearable Electronic Skin Patches 2023-2033" report has been added to ResearchAndMarkets.com s offering. The Global.